Luisa Mari

Systemic Activation of Nrf2 Pathway in Parkinson's Disease

Sara Petrillo, Tommaso Schirinzi, Giulia Di Lazzaro et al. · Movement Disorders · 2019 · 93 citations

Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study

Claudio Liguori, Francesca Izzi, Natalia Manfredi et al. · Epilepsy & Behavior · 2018 · 46 citations

First Add-on Therapy, Medicine, Psychotropic Medication +6

Systemic Activation of Nrf2 Pathway in Parkinson's Disease

Sara Petrillo, Tommaso Schirinzi, Giulia Di Lazzaro et al. · Zenodo (CERN European Organization for Nuclear Research) · 2019 · 36 citations · Full text

Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis

Claudio Liguori, Luigi Ferini‐Strambi, Francesca Izzi et al. · British Journal of Clinical Pharmacology · 2018 · 27 citations · Full text

Sleep Disorders, Sleep Health, Vor Mechanism +21

18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment

Mariana Fernandes, Luisa Mari, Agostino Chiaravalloti et al. · Journal of Neurology · 2022 · 27 citations · Full text